Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 5 (May)

1. The XPC poly-AT polymorphism in non-melanoma skin cancer.
   Cancer Lett, 222(2): 205-9. [Abstract] [Full-text]
2. Test-retest of self-reported exposure to artificial tanning devices, self-tanning creams, and sun sensitivity showed consistency.
   J Clin Epidemiol, 58(4): 430-2. [Abstract] [Full-text]
3. Modulation of skin tumorigenesis by SOD.
   Biomed Pharmacother, 59(4): 209-14. [Abstract] [Full-text]
4. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system.
   Ann Surg Oncol, 12(4): 282-8. [Abstract] [Full-text]
5. Chemoprevention of UV light-induced skin tumorigenesis by inhibition of the epidermal growth factor receptor.
   Cancer Res, 65(9): 3958-65. [Abstract] [Full-text]
6. Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB Irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice.
   Cancer Res, 65(9): 3577-85. [Abstract] [Full-text]
7. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
   Int J Dermatol, 44(5): 428-34. [Abstract] [Full-text]
8. UVB phototherapy and skin cancer risk: a review of the literature.
   Int J Dermatol, 44(5): 355-60. [Abstract] [Full-text]
9. Sodium ascorbate (vitamin C) induces apoptosis in melanoma cells via the down-regulation of transferrin receptor dependent iron uptake.
   J Cell Physiol, 204(1): 192-7. [Abstract] [Full-text]
10. Cutaneous angiomatosis in a young dog.
    Vet Pathol, 42(3): 378-81. [Abstract] [Full-text]
11. Perineural spread of cutaneous malignancy to the brain: a review of the literature and five patients treated with stereotactic radiotherapy.
    Cancer, 103(10): 2143-53. [Abstract] [Full-text]
12. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach.
    Dis Colon Rectum, 48(3): 444-50. [Abstract] [Full-text]
13. Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma.
    Eur J Haematol, 74(6): 526-8. [Abstract] [Full-text]
14. Cytogenetic alterations in nonmelanoma skin cancer: a review.
    Genes Chromosomes Cancer, 43(3): 239-48. [Abstract] [Full-text]
15. 5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma.
    Exp Dermatol, 14(6): 429-37. [Abstract] [Full-text]
16. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: overexpression and redistribution in psoriasis and cutaneous carcinomas.
    Exp Dermatol, 14(6): 420-8. [Abstract] [Full-text]
17. Treatment of advanced malignant eccrine poroma with locoregional chemotherapy.
    Br J Dermatol, 152(5): 1051-5. [Abstract] [Full-text]
18. Utility of the Wood's light: five cases from a pigmented lesion clinic.
    Br J Dermatol, 152(5): 1039-44. [Abstract] [Full-text]
19. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
    Br J Dermatol, 152(5): 1026-9. [Abstract] [Full-text]
20. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001.
    Br J Dermatol, 152(5): 997-1000. [Abstract] [Full-text]
21. High plasma proteasome levels are detected in patients with metastatic malignant melanoma.
    Br J Dermatol, 152(5): 948-53. [Abstract] [Full-text]
22. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
    Br J Dermatol, 152(5): 939-47. [Abstract] [Full-text]
23. Microarray analysis of phosphatase gene expression in human melanoma.
    Br J Dermatol, 152(5): 925-30. [Abstract] [Full-text]
24. Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi.
    Br J Dermatol, 152(5): 909-14. [Abstract] [Full-text]
25. Acquired symmetrical dermal melanocytosis (naevus of Hori) developing after aggravated atopic dermatitis.
    Br J Dermatol, 152(5): 903-8. [Abstract] [Full-text]
26. Single genetic mutations can account for melanocytic naevi.
    Br J Dermatol, 152(5): 896-902. [Abstract] [Full-text]
27. PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer.
    Br J Dermatol, 152(5): 868-73. [Abstract] [Full-text]
28. Photodynamic therapy in dermatology--an update.
    Photodermatol Photoimmunol Photomed, 21(3): 142-9. [Abstract] [Full-text]
29. Subepidermal cleft formation as a diagnostic marker for cutaneous malignant melanoma.
    Hum Pathol, 36(4): 412-5. [Abstract] [Full-text]
30. Multi-spectral image analysis and classification of melanoma using fuzzy membership based partitions.
    Comput Med Imaging Graph, 29(4): 287-96. [Abstract] [Full-text]
31. Mouse skin tumor promotion by sodium arsenate is associated with enhanced PCNA expression.
    Cancer Lett, 223(1): 27-35. [Abstract] [Full-text]
32. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
    Oncogene, 24(21): 3535-40. [Abstract] [Full-text]
33. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.
    Oncogene, 24(21): 3459-71. [Abstract] [Full-text]
34. Capsule endoscopy for the diagnosis and follow-up of blue rubber bleb nevus syndrome.
    Dig Liver Dis, 37(6): 451-3. [Abstract] [Full-text]
35. Histone deacetylase inhibitors and malignant melanoma.
    Pigment Cell Res, 18(3): 160-6. [Abstract] [Full-text]
36. Adhesion, migration and communication in melanocytes and melanoma.
    Pigment Cell Res, 18(3): 150-9. [Abstract] [Full-text]
37. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania.
    Arch Dermatol, 141(5): 579-86. [Abstract] [Full-text]
38. Aesthetic surgery techniques after excision of dermatofibrosarcoma protuberans: a case report.
    Br J Plast Surg, 58(4): 556-60. [Abstract] [Full-text]
39. Soluble branched (1,4)-beta-D-glucans from Acetobacter species enhance antitumor activities against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response.
    Int J Cancer, 115(5): 769-76. [Abstract] [Full-text]
40. Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists.
    Int J Cancer, 115(5): 828-34. [Abstract] [Full-text]
41. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast.
    Am J Clin Pathol, 123(6): 866-73. [Abstract] [Full-text]
42. Multicenter evaluation of the analytical and clinical performance of the Elecsys S100 immunoassay in patients with malignant melanoma.
    Clin Chem Lab Med, 43(5): 557-63. [Abstract] [Full-text]
43. Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines.
    Br J Cancer, 92(10): 1881-91. [Abstract] [Full-text]
44. Pigmentary characteristics and moles in relation to melanoma risk.
    Int J Cancer, 116(1): 144-9. [Abstract] [Full-text]
45. Improved correlation of histological data with DCE MRI parameter maps by 3D reconstruction, reslicing and parameterization of the histological images.
    Eur Radiol, 15(6): 1079-86. [Abstract] [Full-text]
46. The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry.
    J Clin Oncol, 23(15): 3390-5. [Abstract] [Full-text]
47. Solaria compliance in an unregulated environment: the Australian experience.
    Eur J Cancer, 41(8): 1178-84. [Abstract] [Full-text]
48. P2Y purinergic receptors regulate the growth of human melanomas.
    Cancer Lett, 224(1): 81-91. [Abstract] [Full-text]
49. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma.
    Histopathology, 46(6): 614-21. [Abstract] [Full-text]
50. Human herpesvirus type 6 and type 1 infection increases susceptibility to nonmelanoma skin tumors.
    Cancer Lett, 224(2): 213-9. [Abstract] [Full-text]
51. Inhibition of tumour promotion in mouse skin by extracts of rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), unique South African herbal teas.
    Cancer Lett, 224(2): 193-202. [Abstract] [Full-text]
52. Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism.
    Mutat Res, 574(1): 105-11. [Abstract] [Full-text]
53. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.
    Clin Chem, 51(6): 981-8. [Abstract] [Full-text]
54. An intervention for parents to promote preschool children's sun protection: effects of Sun Protection is Fun!
    Prev Med, 41(2): 357-66. [Abstract] [Full-text]
55. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
    Pediatr Dermatol, 22(3): 254-6. [Abstract] [Full-text]
56. Childhood subungual melanoma in situ in diffuse nail melanosis beginning as expanding longitudinal melanonychia.
    Pediatr Dermatol, 22(3): 210-2. [Abstract] [Full-text]
57. Dermoscopy of an acral congenital melanocytic nevus.
    Pediatr Dermatol, 22(3): 188-91. [Abstract] [Full-text]
58. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study.
    J Clin Oncol, 23(16): 3733-41. [Abstract] [Full-text]
59. Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions.
    Am J Clin Pathol, 124(1): 37-48. [Abstract] [Full-text]
60. Experimental model of pulmonary metastasis treatment with IFNalpha.
    Cancer Lett, 225(1): 75-83. [Abstract] [Full-text]
61. Practical considerations for electron beam small field size dosimetry.
    Med Dosim, 30(2): 104-6. [Abstract] [Full-text]
62. Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin.
    Int J Cancer, 116(2): 193-9. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.